Dynamics of the Humoral Immune Response to a Prime-Boost Ebola Vaccine: Quantification and Sources of Variation

The Ebola vaccine based on Ad26.ZEBOV/MVA-BN-Filo prime-boost regimens is being evaluated in multiple clinical trials. The long-term immune response to the vaccine is unknown, including factors associated with the response and variability around the response. We analyzed data from three phase 1 tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasin, Chloé, Balelli, Irene, Van Effelterre, Thierry, Bockstal, Viki, Solforosi, Laura, Prague, Mélanie, Douoguih, Macaya, Thiébaut, Rodolphe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2019
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714808/
https://www.ncbi.nlm.nih.gov/pubmed/31243126
http://dx.doi.org/10.1128/JVI.00579-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714808/
https://www.ncbi.nlm.nih.gov/pubmed/31243126
http://dx.doi.org/10.1128/JVI.00579-19

Ejemplares similares